A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis

Name: A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis
Published: 2026
License: Public Domain

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

chronic rhinosinusitis with nasal polyps, cm326，anti-tslp biologics, chronic rhinosinusitis with nasal polyps，allergy, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis

Related documents